Associated Papers
Rethinking 'rare' PINK1 Parkinson's disease: A meta-analysis of geographical prevalence, phenotypic diversity, and α-synuclein pathology.
Yin EP et al.
Journal of Parkinson's Disease, 2025
HMOX1 genetic polymorphisms and outcomes in infectious disease: A systematic review.
Hamilton FW et al.
Plos One, 2022
35551540 (PubMed )
Supplement: pone.0267399.s002.xlsx › articles
Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson's Disease.
Zhao J et al.
Molecular Neurobiology, 2017
Increase of oxidative stress by a novel PINK1 mutation, P209A.
Chien WL et al.
Free Radical Biology & Medicine, 2013
Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.
Nuytemans K et al.
Human Mutation, 2010
20506312 (PubMed )
Supplement: humu0031-0763-SD1.pdf
Genotype-phenotype correlates in Taiwanese patients with early-onset recessive Parkinsonism.
Lee MJ et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2009
Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1.
Weihofen A et al.
Human Molecular Genetics, 2008
Select a paper to view details